Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
7/8
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

7 Years

13 Years 8 Months

Fund AUM

₹950 Cr

₹8636 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹1000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.84%

0.79%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

40

37

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(12.42%)
  2. Apollo Hospitals Enterprise Ltd(7.31%)
  3. Torrent Pharmaceuticals Ltd(4.75%)
  4. J.B. Chemicals & Pharmaceuticals Ltd(4.73%)
  5. Aurobindo Pharma Ltd(4.37%)
  1. Sun Pharmaceuticals Industries Ltd(13.35%)
  2. Lupin Ltd(7.31%)
  3. Dr Reddy's Laboratories Ltd(6.72%)
  4. Cipla Ltd(6.16%)
  5. Divi's Laboratories Ltd(5.8%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(99.33%)
  2. Basic Materials(0.67%)

Health

(100%)

Equity %

96.83%

97.92%

Debt %

-

-

P/E

38.55

36.71

P/B

5.7

5.41

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

2.01%

1.75%

3-Month Return

11.95%

10.33%

6-Month Return

12.25%

8.38%

1-Year Return

15.2%

8.74%

3-Year Return

24.76%

22.62%

5-Year Return

14.81%

13.86%

Sharpe

1.1

1.03

Alpha

0.72

-0.47

Beta

0.92

0.9

Standard Deviation

16.17

15.79

Information Ratio

-0.19

-0.65

Description

Aditya Birla Sun Life Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhaval Shah

Sailesh Raj Bhan, Amber Singhania, Kinjal Desai

Most Popular Comparisons